Jasper Therapeutics Inc
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercializ… Read more
Market Cap & Net Worth: Jasper Therapeutics Inc (JSPR)
Jasper Therapeutics Inc (NASDAQ:JSPR) has a market capitalization of $34.98 Million ($34.98 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24041 globally and #8344 in its home market, demonstrating a -9.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jasper Therapeutics Inc's stock price $1.25 by its total outstanding shares 27984039 (27.98 Million).
Jasper Therapeutics Inc Market Cap History: 2020 to 2026
Jasper Therapeutics Inc's market capitalization history from 2020 to 2026. Data shows change from $2.80 Billion to $34.98 Million (-50.61% CAGR).
Index Memberships
Jasper Therapeutics Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #647 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2114 of 3165 |
Weight: Jasper Therapeutics Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Jasper Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jasper Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
10.00x
Jasper Therapeutics Inc's market cap is 10.00 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $2.20 Billion | $6.20 Million | -$30.64 Million | 354.54x | N/A |
| 2022 | $135.16 Million | $13.51 Million | -$37.69 Million | 10.00x | N/A |
Competitor Companies of JSPR by Market Capitalization
Companies near Jasper Therapeutics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Jasper Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Jasper Therapeutics Inc Historical Marketcap From 2020 to 2026
Between 2020 and today, Jasper Therapeutics Inc's market cap moved from $2.80 Billion to $ 34.98 Million, with a yearly change of -50.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $34.98 Million | -31.69% |
| 2025 | $51.21 Million | -91.44% |
| 2024 | $598.30 Million | +170.98% |
| 2023 | $220.79 Million | +63.35% |
| 2022 | $135.16 Million | -93.85% |
| 2021 | $2.20 Billion | -21.58% |
| 2020 | $2.80 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Jasper Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.98 Million USD |
| MoneyControl | $34.98 Million USD |
| MarketWatch | $34.98 Million USD |
| marketcap.company | $34.98 Million USD |
| Reuters | $34.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.